Licensing Opportunities

  • Cell targeting conjugates

  • Gastric cancer biomarker

  • NMP for multiple myeloma and anti-inflammatory

  • Polygen

  • Radiosphere

  • Ryk antibody

  • Radioprotectors

If you are interested in any of the technologies listed above, please contact the TTO for more details.